Patents/Inventors

Abraham J. Langseth

Stamford, CTUS12 patents

14 Patents

US123904302025
Mirdametinib Treatment
Springworks Therapeutics, Inc.
0 cites
US123835172025
Dosage Forms of Mirdametinib
Spring Works Therapeutics, Inc.
0 cites
US123247912025
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US122959252025
Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) in Pediatric Patients with Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US122631462025
Non-linear Dosing of Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US122572152025
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US122203902025
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US120297112024
Dosage Forms of Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US120114242024
Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) in Pediatric Patients with Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US118833752024
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US118395952023
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US118194872023
Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) in Pediatric Patients with Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US118063212023
Non-linear Dosing of Mirdametinib
SPRINGWORKS THERAPEUTICS, Inc.
0 cites
US118063222023
Mirdametinib Treatment
SPRINGWORKS THERAPEUTICS, Inc.
0 cites